Edward B. Diethrich – författare

In excess of 7 million people worldwide die of coronary heart disease each year.  Only one-third of these heart attack victims recover completely.  The remainder suffer the consequences of myocardial infarction and its ill fated remodeling process, resulting in chronic congestive heart failure.  This malady alone is the leading cause of hospital admissions in the United States.

New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair.  World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease.  These contributions in basic science, pre-clinical and clinical experience guided by the regulatory pathways, assure a rapid course of translational research and clinical trials.

 The contents of this publication will become a prerequisite for those preparing to meet the challenges of this exciting and potentially rewarding field of stem cell research.

Written by physicians at the Arizona Heart Institute, which pioneered the use of thoracic endoluminal grafts, Endovascular and Hybrid Management of the Thoracic Aorta presents clinical scenarios as well as controversies in this fascinating and rapidly developing field.

Discussing the etiology, diagnostic tools and management and treatment of specific pathologies of the aorta, this book is ideal for cardiovascular and vascular surgeons from all over the world. It is also of interest to residents in vascular and cardiothoracic surgery who have an interest in thoracic aortic disease management and want to be at the forefront of endovascular technology.

Focusing on both the entire range of angioplasty and stenting treatment options for the surgeon treating patients on the operating table, and the range of radiological techniques used for the cardiologist to diagnose carotid artery stenosis (CAS) and associated conditions, this important book describes the best indications, the different techniques, the results, and also the limitations of CAS based on randomized studies and particularly the last published data (CREST study).

Suitable for both novice and experienced interventionalists, it also addresses diagnosis of a carotid stenosis and complications from CAS and how to manage them.

Focusing on both the entire range of angioplasty and stenting treatment options for the surgeon treating patients on the operating table, and the range of radiological techniques used for the cardiologist to diagnose carotid artery stenosis (CAS) and associated conditions, this important book describes the best indications, the different techniques, the results, and also the limitations of CAS based on randomized studies and particularly the last published data (CREST study).

Suitable for both novice and experienced interventionalists, it also addresses diagnosis of a carotid stenosis and complications from CAS and how to manage them.

Written by physicians at the Arizona Heart Institute, which pioneered the use of thoracic endoluminal grafts, Endovascular and Hybrid Management of the Thoracic Aorta presents clinical scenarios as well as controversies in this fascinating and rapidly developing field.

Discussing the etiology, diagnostic tools and management and treatment of specific pathologies of the aorta, this book is ideal for cardiovascular and vascular surgeons from all over the world. It is also of interest to residents in vascular and cardiothoracic surgery who have an interest in thoracic aortic disease management and want to be at the forefront of endovascular technology.